- Home
- XOMA
XOMA
XOMA Corporation
as 04-21-2025 2:45pm EST
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
| Founded: | 1981 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | 250.1M | IPO Year: | N/A |
| Target Price: | $59.67 | AVG Volume (30 days): | 26.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.35 - $35.00 | Next Earning Date: | 05-08-2025 |
| Revenue: | $28,487,000 | Revenue Growth: | 498.72% |
| Revenue Growth (this year): | 14.22% | Revenue Growth (next year): | 34.01% |
Latest XOMA Corporation News
XOMA Breaking Stock News: Dive into XOMA Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 days ago
XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability
GlobeNewswire
7 days ago
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
Insider Monkey
12 days ago
XOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout
Argus Research
12 days ago
Daily – Vickers Top Buyers & Sellers for 04/09/2025
GlobeNewswire
19 days ago
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
GlobeNewswire
a month ago
XOMA Royalty Declares Quarterly Preferred Stock Dividends
Simply Wall St.
a month ago
XOMA Royalty Full Year 2024 Earnings: EPS Misses Expectations
GlobeNewswire
a month ago
XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements
Compare XOMA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XOMA XOMA Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.